Status:
COMPLETED
Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation
Lead Sponsor:
Sisli Hamidiye Etfal Training and Research Hospital
Conditions:
Anesthesia
Eligibility:
All Genders
1-10 years
Phase:
PHASE4
Brief Summary
Sixty patients aged between 1-10 years, American Society of Anesthesia (ASA) physical status I-II scheduled for MRI were allocated in this randomized double-blinded study. Group 1 received 3 mcg/kg, G...
Detailed Description
OBJECTIVES OF STUDY Anesthetic agents used for MRI in paediatrics should have few adverse effects, allow fast induction and recovery. The administration route is also important and should be minimally...
Eligibility Criteria
Inclusion
- MRI
- ASA I-II
Exclusion
- hepatic and renal failure
- difficult airway
- nasal deformity
- anaphylaxis to dexmedetomidine
- neurologic disease
- metabolic disorders
- electrolyte imbalance
- dehydration
- malnutrition
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02299232
Start Date
February 1 2014
End Date
April 1 2014
Last Update
October 25 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.